CH Biotech R&D Co., Ltd. (TPE:6534)
Taiwan · Delayed Price · Currency is TWD 119.00
+0.50 (0.42%)
Sep 1, 2025, 9:52 AM CST
CH Biotech R&D Market Cap
CH Biotech R&D has a market cap or net worth of 12.18 billion as of August 29, 2025. Its market cap has increased by 47.39% in one year.
Market Cap
12.18B
Enterprise Value
12.44B
Revenue
1.68B
Ranking
n/a
PE Ratio
33.59
Stock Price
119.00
Market Cap Chart
Since July 2, 2015, CH Biotech R&D's market cap has increased from 7.47B to 12.18B, an increase of 63.08%. That is a compound annual growth rate of 4.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 12.18B | 46.66% |
| Dec 31, 2024 | 8.31B | 0.37% |
| Dec 29, 2023 | 8.28B | 13.05% |
| Dec 30, 2022 | 7.32B | 42.15% |
| Dec 30, 2021 | 5.15B | 20.79% |
| Dec 31, 2020 | 4.26B | -25.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nan Ya Plastics | 342.61B |
| China Steel | 306.36B |
| Formosa Plastics | 247.95B |
| Formosa Chemicals & Fibre | 176.06B |
| TCC Group Holdings | 169.08B |
| Asia Cement | 131.40B |
| Taiwan Glass Ind. | 102.65B |
| Walsin Lihwa | 101.03B |